Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing

Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing

Human mesenchymal stromal cell (hMSC) therapy has been gaining immense interest in regenerative medicine and quite recently for its immunomodulatory properties in COVID-19 treatment. Currently, the use of hMSCs for various diseases is being investigated in >900 clinical trials. Despite the hu...

Full description

Bibliographic Details
Main Authors: Premkumar Jayaraman, Ryan Lim, Jacqueline Ng, Mohan C. Vemuri
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
mesenchymal stromal cells
cell therapy
GMP manufacturing
closed and automation systems
characterization and potency
regulatory compliance
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.648472/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2021.648472/full

Similar Items